LEVODIXIN

This brand name is authorized in Nigeria.

Active ingredients

The drug LEVODIXIN contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII HTN0D03VRZ - LEVOFLOXACIN HYDROCHLORIDE
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6520	Caplet	LEVODIXIN CAPLETS TAB 500 mg 27	LEVODIXIN CAPLETS LEVOFLOXACIN 500MG LEVOFLOXACIN HYDROCHLORIDE EQV TO LEVOFLOXACIN 500MG, MICROCRYSTALLINE CELLULOSE 113.6MG, SODIUM STARCH GLYCOLATE 68.2MG, ETHANOL 122.7MG, POVIDONE K30 340.9MG, MAGNESIUM STEARATE 5.7MG, PURIFIED WATER 71.6MG B4-6520 Drugs Imported Products 27 Prescription Only Medicine (POM) 12/08/2021 DAITECH PHARMACEUTICALS LTD, BLOCK B4, COUNTESS COURT, MABUSHI, ABUJA, FCT, NIGERIA 92919163 daitechpharma@gmail.com JIANGSU PENGYAO PHARM CO. LTD, 10, CHAQUAN ROAD, YIXING CITY, JIANGSU PROVINCE CHINA, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6520